Voor zorgverleners

BioDay-register: 5 jaar ervaring met dupilumab

Wat leren we uit de real-world data van het BioDay-register, waar 1.286 met dupilumab behandelde patiënten over vijf jaar gevolgd zijn?

BRIGHT publication

Diagnostic Algorithm

Diagnostic and confirmation testing

Gaucher disease is rare and has signs and symptoms that can be confused with those of many other diseases. However, some tests allow the definitive diagnosis of the disease.

Understanding Gaucher Disease: Genetics, Transmission, and Family Screening

Understanding Gaucher Disease: Symptoms, Classification, and Clinical Presentation

Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.¹

The RESTORE-G Real World Evidence Study

RESTORE-G: Real-world analysis in insulin-naïve adults with T2D on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†2

Advancing the treatment: Meeting the challenge of uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives⁸.

Underneath the skin

What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?